Cable Hill Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$208K Sell
4,137
-578
-12% -$33.7K 0.02% 206
2024
Q4
$267K Sell
4,715
-1,000
-17% -$55.9K 0.03% 163
2024
Q3
$296K Buy
+5,715
New +$268K 0.03% 151
2023
Q2
Sell
-3,178
Closed -$220K 187
2023
Q1
$220K Buy
3,178
+268
+9% +$18.9K 0.04% 181
2022
Q4
$209K Sell
2,910
-43
-1% -$3.24K 0.04% 186
2022
Q3
$210K Buy
+2,953
New +$214K 0.04% 146
2019
Q2
Sell
-1,430
Closed -$68K 191
2019
Q1
$68K Buy
1,430
+3
+0.2% +$149 0.02% 220
2018
Q4
$74K Buy
1,427
+4
+0.3% +$215 0.03% 189
2018
Q3
$89K Buy
1,423
+3
+0.2% +$178 0.04% 121
2018
Q2
$79K Buy
1,420
+3
+0.2% +$162 0.03% 136
2018
Q1
$86K Sell
1,417
-24
-2% -$1.54K 0.04% 128
2017
Q4
$89K Sell
1,441
-93
-6% -$5.82K 0.04% 157
2017
Q3
$98K Buy
1,534
+125
+9% +$7.3K 0.05% 158
2017
Q2
$79K Buy
1,409
+3
+0.2% +$163 0.04% 110
2017
Q1
$76K Buy
1,406
+3
+0.2% +$165 0.04% 107
2016
Q4
$82K Sell
1,403
-1,258
-47% -$68.8K 0.04% 106
2016
Q3
$146K Buy
+2,661
New +$171K 0.1% 68
2016
Q2
Sell
-61
Closed -$4.31K 694
2016
Q1
$4K Sell
61
-43
-41% -$2.71K ﹤0.01% 502
2015
Q4
$8K Hold
104
0.01% 387
2015
Q3
$7K Sell
104
-90
-46% -$5.71K 0.01% 428
2015
Q2
$14K Hold
194
0.01% 368
2015
Q1
$12K Sell
194
-38
-16% -$2.38K 0.01% 393
2014
Q4
$14K Buy
+232
New +$13.1K 0.01% 363

Other funds holding BMY

Cable Hill Partners's BMY Position: Q1 2025 in Review

Cable Hill Partners reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2025, selling an estimated $33.7K and leaving 4,137 shares worth $208K. The position accounts for 0.02% of the portfolio, ranked #206.

Cable Hill Partners first reported a position in BMY in Q4 2014 and has held it in 23 quarters since. The position peaked at $296K in Q3 2024. 2,479 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Cable Hill Partners held 4,137 shares of Bristol-Myers Squibb worth $208K as of Q1 2025.
  • Cable Hill Partners sold 578 Bristol-Myers Squibb shares in Q1 2025, an estimated $33.7K.
  • Bristol-Myers Squibb made up 0.02% of Cable Hill Partners's portfolio in Q1 2025, its #206 holding.
  • Cable Hill Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 23 quarters since.
  • Cable Hill Partners's Bristol-Myers Squibb position peaked at $296K in Q3 2024.
  • 2,479 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.